Purine-specific nucleoside N-ribohydrolase from Trypanosoma brucei brucei. Purification, specificity, and kinetic mechanism.
Trypanosomes have no de novo purine biosynthesis and thus depend upon salvage pathways to obtain purines for their metabolic pathways and for the biosynthesis of nucleic acids. An inosine-adenosine-guanosine preferring nucleoside hydrolase (IAG-nucleoside hydrolase) from the African trypanosome Trypanosoma brucei brucei represents approximately 0.2% of the soluble protein in this organism. The enzyme has been purified over 400-fold to >95% homogeneity from the bloodstream form of this parasite. IAG-nucleoside hydrolase is a dimer of Mr 36,000 subunits. The kcat/Km for inosine, adenosine, and guanosine are 1.9 x 10(6), 1.2 x 10(6), and 0.83 x 10(6) M -1 s-1, respectively. The kinetic mechanism with inosine as substrate is rapid equilibrium with random product release. The turnover rate for inosine at 30 degrees C is 34 s-1. Pyrimidine nucleosides are poor substrates with kcat/Km values of approximately 10(3) M -1 s-1. Deoxynucleosides are also poor substrates with kcat/Km values near 10(2) M -1 s-1. AMP is not a detectable substrate and there is no measurable purine nucleoside phosphorylase activity. 3-Deazaadenosine, 7-deazaadenosine (tubercidin), and formycin B are competitive inhibitors with Kis of 1.8, 59, and 13 microM, respectively. The Km shows a slight dependence on pH with a pH optimum around 7. The Vmax/Km data indicate there are two ionizable enzymatic groups, pKa 8.6, required for the formation of the Michaelis complex. The Vmax data indicate three ionizable groups involved in catalysis. Two essential groups exhibit pKa values of 8.8, and a third group with a pKa of 6.5 increases the Vmax an additional 10-fold. All three groups must be protonated for optimum catalytic activity.
Parkin
D W
DW
International Livestock Research Institute, Nairobi, Kenya.
D000818:Animals; D002850:Chromatography, Gel; D004591:Electrophoresis, Polyacrylamide Gel; D006863:Hydrogen-Ion Concentration; D019271:Hypoxanthine; D007042:Hypoxanthines / Q000494:pharmacology; D007700:Kinetics; D008970:Molecular Weight; D009699:N-Glycosyl Hydrolases / Q000302:isolation & purification* / Q000378:metabolism; D011683:Purine-Nucleoside Phosphorylase / Q000378:metabolism; D012266:Ribose / Q000494:pharmacology; D013379:Substrate Specificity; D014346:Trypanosoma brucei brucei / Q000201:enzymology*
D007042:Hypoxanthines; D019271:Hypoxanthine; D012266:Ribose; D011683:Purine-Nucleoside Phosphorylase; D009699:N-Glycosyl Hydrolases; C041035:inosine-guanosine hydrolase; C030681:purine nucleosidase